In around 90 percent of PsA cases, the joint symptoms only appear after the skin manifestations. Scientific studies have shown that a delayed PsA diagnosis can have unfavorable prognostic implications. Recently published consensus recommendations therefore suggest that patients with plaque psoriasis should be screened for joint involvement once or twice a year. Various screening methods can be combined.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Contact eczema
Causes and prevention at work
- Pulmonary hypertension
PH and lung diseases
- Respiratory infections: viral bronchitis or bacterial pneumonia?
Old crucial question in the light of current findings
- What biomarkers reveal about "biological youth" - and what not (yet)
Epigenetic ageing
- Amyotrophic lateral sclerosis and nutrition
Calorie optimization in ALS through digital intervention
- "Forgotten axis" between plant substances, gut and systemic health
Microbiome and phytotherapy
- HIV: updated EACS guideline
Individualized approach to sustainable prevention and care
- Evidence-based diagnostics and treatment in the medical setting